CNIO-CaixaResearch Frontiers Meeting: Frontiers in Immunomodulation and Cancer Therapy
Añadir al calendario
- Tipo de evento
- Congreso
- Fecha
- Del 16 al 18 de octubre de 2024
- Lugar del evento
- CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS - CNIO Auditorio - Madrid - España
- Organizado por
- CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS - CNIO y FUNDACIÓN LA CAIXA
- Teléfono
- 917 328 000
- eventos@cnio.es
- Página web
- https://www.cnio.es/en/eventos/frontiers-in-immunomodulation-and-cancer-therapy-2nd-edition-2/
- Coordinadores científicos
- Speakers:Yasmine Belkaid - Pasteur Institute, Paris, FranceMark Cragg - Southampton General Hospital; University of Southampton, Southampton, UKKarin de Visser - The Netherlands Cancer Institute, Amsterdam, NetherlandsSandra Demaria - Weill Cornell Medical College, New York, USFlorent Ginhoux - Gustave Roussy, Villejuif Cedex, FranceIlaria Malanchi - The Francis Crick Institute, London, UKKenneth Murphy - Washington University in St. Louis, Washington, USHai Qi - Institute for Immunology, Tsinghua University, Beijing, ChinaCaetano Reis e Sousa - The Francis Crick Institute, London, UKBoris Reizis - NYU Grossman School of Medicine, New York, USBruno Silva-Santos - Institute of Molecular Medicine (IMM) João Lobo Antunes, Lisboa, PortugalRamnik Xavier - Broad Institute, Cambridge, US
- Secretaría técnica
- CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS
- Comité organizador
- Luis Alvarez-Vallina, CNIO, Madrid, SpainMaria Casanova-Acebes, CNIO, Madrid, SpainNabil Djouder, CNIO, Madrid, SpainDavid Sancho, CNIC, Madrid, SpainXin (Cindy) Sun, JEM, New York, US
Información sobre el evento
The immune system has the ability to recognize and kill tumor cells. However, tumors may invade the immune system generating an immunosuppressive tumor microenvironment making tumors resistant to immunotherapies. This conference will focus and discuss recent findings on mechanistic insights of immune escape machinery, immunotolerence and immunomodulation. We will address how tumors can escape the immune system creating an immunosuppressive tumor microenvironment and how tumours become resistant to immunothepary. This conference will also present an overview of pre-clinical and emerging clinical advances targeting the immune system for treatment of cancer or cancer-associated disorders.
Topics to be covered:
• Targeting the tumor microenvironment
• Immune system engineering and vaccination strategies in solid tumors
• Immunomodulation and immunotolerence
• Microbiome and metabolism in immunology
• Neuroimmunomodulation
FECHA LÍMITE DE INSCRIPCIÓN 1/10/2024
FECHA LÍMITE DE ENVÍO DE RESUMEN 16/09/2024
PRECIO 200 Euro Students and CNIO staff; 400 Euro Post-docs and Academia; 600 Euro Industry.